Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Thiazolidinediones: the Forgotten Diabetes Medications
Harold E. Lebovitz
Current Diabetes Reports (2019) Vol. 19, Iss. 12
Open Access | Times Cited: 295

Showing 76-100 of 295 citing articles:

Functional and Structural Insights into Human PPARα/δ/γ Subtype Selectivity of Bezafibrate, Fenofibric Acid, and Pemafibrate
Akihiro Honda, S Kamata, Makoto Akahane, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4726-4726
Open Access | Times Cited: 19
Evaluation of acute oral toxicity, anti-diabetic and antioxidant effects of Aloe vera flowers extract
Nesreen M. I. M. Elkomy, Amina El‐Shaibany, Gehad M. Elnagar, et al.
Journal of Ethnopharmacology (2023) Vol. 309, pp. 116310-116310
Closed Access | Times Cited: 12
Association of Pioglitazone With Major Adverse Cardiovascular Events, All-Cause Mortality, and Heart Failure Hospitalizations: A Systematic Review
Ibrahimkhalil M Sheikh, Omar A Hassan, Siad Mohammed Adam, et al.
Cureus (2023)
Open Access | Times Cited: 11
Antidiabetic potential of thiazolidinedione derivatives with efficient design, molecular docking, structural activity relationship, and biological activity: an update review (2021–2023)
Anchal Sharma, Nitish Kumar, Harmandeep Kaur Gulati, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 4
Combined Placental Mesenchymal Stem Cells with Guided Nanoparticles Effective Against Diabetic Nephropathy in Mouse Model
Ke Wang, Te Liu, Yucheng Zhang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 901-915
Open Access | Times Cited: 4
Quantitative determination of lobeglitazone sulfate and glimepiride in combined tablet by robust high‐performance thin layer chromatographic method
Ashim Kumar Sen, Tantul Sarkar, Dhanya B. Sen, et al.
Separation Science Plus (2024) Vol. 7, Iss. 7
Closed Access | Times Cited: 4
Structure-based screening, optimization and biological evaluation of novel chrysin-based derivatives as selective PPARγ modulators for the treatment of T2DM and hepatic steatosis
Lei Ma, Junyuan Tang, Fangyuan Chen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116728-116728
Closed Access | Times Cited: 4
Advances in the Insulin–Heart Axis: Current Therapies and Future Directions
Alfredo Caturano, Erica Vetrano, Raffaele Galiero, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10173-10173
Open Access | Times Cited: 4
Attenuation of Endothelial Dysfunction in Diabetes Mellitus: An Integral Characteristic of Anti-Diabetic Medications
Chidiebere V. Ugwueze
Journal of Diabetology (2025) Vol. 16, Iss. 1, pp. 1-13
Open Access
Recent Advances in Promoting Bone Regeneration in Type 2 Diabetes Using Drug Delivery Vehicles and Vehicle‐Free Therapeutics
Yasamin Pesaran Afsharian, Mostafa Rahimnejad, Sayed Mahmood Rabiee, et al.
Advanced Therapeutics (2025)
Closed Access
A Computational Study of New Glitazones‐Sulphonylureas Hybrids as Potential Antidiabetic Agents
Kabelo Phuti Mokgopa, Adedapo S. Adeyinka, Simon S. Mnyakeni‐Moleele, et al.
ChemistrySelect (2025) Vol. 10, Iss. 3
Open Access
Thiazolidinedione derivatives: emerging role in cancer therapy
Ganesh Latambale, Kapil Juvale
Molecular Diversity (2025)
Closed Access
Compromised PPARγ Mediated Impaired Placental Glucose Transport via the PI3K/AKT Signaling Pathway is Associated with FGR
Biao Huang, Hao Wang, Zhongling An, et al.
Laboratory Investigation (2025), pp. 104103-104103
Closed Access
The Many Facets of PPAR-γ Agonism in Obesity and Associated Comorbidities: Benefits, Risks, Challenges, and Future Directions
Dimitris Kounatidis, Natalia G. Vallianou, Eleni Rebelos, et al.
Current Obesity Reports (2025) Vol. 14, Iss. 1
Closed Access
Beyond metformin: the expanding landscape of Type 2 diabetes treatment
Keith Ntokozo Ncube, T D Malange
SA pharmaceutical journal. (2025) Vol. 92, Iss. 1, pp. 30-34
Closed Access
Insight the confirmation of benzothiazolidinone-derived thiadiazole scaffolds as promising antiurease and anti-Alzheimer agents: synthesis, in vitro, and in silico investigations
Shoaib Khan, Tayyiaba Iqbal, Tayyaba Zahoor, et al.
Zeitschrift für Naturforschung C (2025)
Closed Access
Understanding the peroxisome proliferator-activated receptor gamma (PPAR-γ) role in periodontitis and diabetes mellitus: A molecular perspective
Ingra Gagno Nicchio, Thamiris Cirelli, Lucas César da Costa Quil, et al.
Biochemical Pharmacology (2025), pp. 116908-116908
Closed Access
Explaining Type 2 Diabetes with Transcriptomic Signatures of Pancreatic β-Cell Dysfunction and Death Induced by Human Islet Amyloid Polypeptide
Pratiksha H. Roham, Saurabh Singh Yadav, B. Senthilnathan, et al.
OMICS A Journal of Integrative Biology (2025)
Closed Access
Effectiveness of Magnolol, a Lignan from Magnolia Bark, in Diabetes, Its Complications and Comorbidities—A Review
Katarzyna Szałabska-Rąpała, Weronika Borymska, Ilona Kaczmarczyk‐Sedlak
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 10050-10050
Open Access | Times Cited: 26
Antidiabetic drugs and oxidized low-density lipoprotein: A review of anti-atherosclerotic mechanisms
Ali Ahmadi, Yunes Panahi, Thomas P. Johnston, et al.
Pharmacological Research (2021) Vol. 172, pp. 105819-105819
Closed Access | Times Cited: 24
PPARγ Acetylation in Adipocytes Exacerbates BAT Whitening and Worsens Age-Associated Metabolic Dysfunction
Ying He, Ruotong Zhang, Lexiang Yu, et al.
Cells (2023) Vol. 12, Iss. 10, pp. 1424-1424
Open Access | Times Cited: 10
Posttransplant Diabetes Mellitus: Recent Developments in Pharmacological Management of Hyperglycemia
Juan M. Munoz Pena, Kenneth Cusi
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 109, Iss. 1, pp. e1-e11
Open Access | Times Cited: 10
Exploring Rosiglitazone’s Potential to Treat Alzheimer’s Disease through the Modulation of Brain-Derived Neurotrophic Factor
Mackayla L. Nelson, Julia A. Pfeifer, Jordan P. Hickey, et al.
Biology (2023) Vol. 12, Iss. 7, pp. 1042-1042
Open Access | Times Cited: 10
Therapeutic application of natural compounds for skeletal muscle-associated metabolic disorders: A review on diabetes perspective
Khurshid Ahmad, Sibhghatulla Shaikh, Jeong Ho Lim, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115642-115642
Open Access | Times Cited: 10
Hyperglycemia-driven signaling bridges between diabetes and cancer
Somayyeh Ghareghomi, Payam Arghavani, Majid Mahdavi, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116450-116450
Closed Access | Times Cited: 3

Scroll to top